Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalized cohort

Posted on | Posted on John Murphy | Leave a Comment on Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalized cohort

Authors: AdamHampshireaDoris A.ChatfieldbAnne ManktelowMPhilbAmyJollyaWilliamTrenderaPeter J.HellyeraMartina DelGiovaneaVirginia F.J.NewcombebJoanne G. Outtrimb BenWarneb JunaidBhattid LindaPointond AnneElmere NyarieSitholebf JohnBradleybgh NathalieKingston lStephen J.Sawceri Edward T.Bullmorecdj…David K.Menonbck1 Volume 47, May 2022, 101417 Summary Background Preliminary evidence has highlighted a possible association between severe COVID-19 and persistent cognitive deficits. Further research is required to confirm this association, determine whether cognitive deficits relate to clinical […]

COVID-19: Omicron variant did not wipe out Delta, it could return

Posted on | Posted on John Murphy | Leave a Comment on COVID-19: Omicron variant did not wipe out Delta, it could return

While the Delta virus wiped out the variants that preceded it, Omicron has not eliminated Delta, according to a new study from Israel’s Ben-Gurion University of the Negev. Authors:  JUDY SIEGEL-ITZKOVICH Published: MAY 2, 2022  Don’t throw away your unused face masks yet. COVID-19’s Omicron variants may burn themselves out in the next couple of months, and the Delta […]

COVID-19 infection could age brain by 20 years, lower IQ significantly

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 infection could age brain by 20 years, lower IQ significantly

Authors: Chris Melore Study Finds May 3, 2022 A severe coronavirus infection could leave patients with the brain of a 70-year-old, lowering someone’s IQ by 10 points, according to a new study. Researchers from the University of Cambridge and Imperial College London found that COVID patients are dealing with levels of cognitive impairment which are […]

Pfizer-BioNTech Vaccine Much Weaker in Kids Against Omicron and More

Posted on | Posted on John Murphy | Leave a Comment on Pfizer-BioNTech Vaccine Much Weaker in Kids Against Omicron and More

Authors: Mark Terry Published: Mar 01, 2022  BIOSPACE Pfizer-BioNTech Vaccine Only 12% Effective Against Omicron in 5-11-Year-Olds  In a new study that is yet to be peer-reviewed, the New York State Department of Health found that the Pfizer–BioNTech vaccine was only about 12% effective for children ages 5 to 11 years against the Omicron variant. In that age group, it […]

Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

Posted on | Posted on John Murphy | Leave a Comment on Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

Current Issues In Molecular Biology Authors: Markus Aldén 1 , Francisko Olofsson Falla 1 , Daowei Yang 1 , Mohammad Barghouth 1 , Cheng Luan 1 , Magnus Rasmussen 2 and Yang De Marinis 1,* Abstract: Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer andBioNTech, showed reversible hepatic effects in animals that received […]

Complications From Taking COVID Vaccine Is 40 Times Higher Than Previously Recorded

Posted on | Posted on John Murphy | Leave a Comment on Complications From Taking COVID Vaccine Is 40 Times Higher Than Previously Recorded

Authors:  Jim Hoft Published May 3, 2022  A new German study with around 40,000 participants concluded that severe complications after receiving the COVID vaccine. The study found that those suffering serious complications is 40 times higher than previously recorded. “The number of severe complications after vaccination against Sars-CoV-2 is 40 times higher than previously recorded […]

Study into mRNA vaccine death rates sends ‘danger signals’

Posted on | Posted on John Murphy | Leave a Comment on Study into mRNA vaccine death rates sends ‘danger signals’

A new Danish study reveals disparities in all-cause mortality between mRNA and adenovirus vaccines Do the covid vaccines save lives? That is the question on many people’s minds, that has led to heated discussions across the world. A bombshell new study by a distinguished team of Danish researchers led by Prof. Christine Stabell-Benn suggests a surprisingly nuanced […]

Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England

Posted on | Posted on John Murphy | Leave a Comment on Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England

Authors: T. Beaney, A. L. Neves, A. Alboksmaty, H. Ashrafian, K. Flott, A. Fowler, J. R. Benger,  P. Aylin, S. Elkin, A. Darzi & J. Clarke  Nature Communications volume 13, Article number: 2356 (2022)  Abstract The Covid-19 mortality rate varies between countries and over time but the extent to which this is explained by the underlying risk in those infected is unclear. Using data on all adults in England with […]

COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care

Last updated April 28, 2022 This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group in collaboration with Laura E. Riley, MD; Richard Beigi, MD; Denise J. Jamieson, MD, MPH; Brenna L. Hughes, MD, MSc; Geeta Swamy, MD; Linda O’Neal Eckert, MD; […]

Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use

Posted on | Posted on John Murphy | Leave a Comment on Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use

Paxlovid, authorized to treat high-risk people early in infection, didn’t meaningfully reduce illness in exposed adults Authors: Jared S. Hopkins Apr. 29, 2022 The Wall Street Journal The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a late-stage study found. Pfizer said Friday that the […]